Ras-regulated hypophosphorylation of the retinoblastoma protein mediates neuronal differentiation in PC12 cells

Journal of Neurochemistry

Volumn 66, Issue 6, 1996, Pages 2287-2294

  Li, Hongzhen ^a   Kawasaki, Hiroshi ^b   Nishida, Eisuke ^b   Hattori, Seisuke ^a   Nakamura, Shun ^a,c  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

Hypophosphorylation; Nerve growth factor; Neuronal differentiation; PC12 cells; Ras; Retinoblastoma protein

Indexed keywords

CYCLIC AMP; EPIDERMAL GROWTH FACTOR; INTERLEUKIN 6; NERVE GROWTH FACTOR; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL STRAIN; GENETIC REGULATION; NERVE CELL; NERVE FIBER GROWTH; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0029890619     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66062287.x     Document Type: Article

References (43)

1. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
2. Buchkovich K., Duffy L. A., and Harlow E. (1989) The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58, 1097-1105.
3. Chen P. L., Scully P., Shew J. Y., Wang J. Y., and Lee W. H. (1989) Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58, 1193-1198.
4. Clarke A. R., Maandag E. R., van Roon M., van der Lugt N. M., van der Valk M., Hooper M. L., Berns A., and te Riele H. (1992) Requirement for a functional Rb-1 gene in murine development. Nature 359, 328-330.
5. Furukawa Y., DeCaprio J. A., Freedman A., Kanakura Y., Nakamura M., Ernst T. J., Livingston D. M., and Griffin J. D. (1990) Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human hematopoietic cells. Proc. Natl. Acad. Sci. USA 87, 2770-2774.
6. Gotoh Y., Moriyama K., Matsuda S., Okumura E., Kishimoto T., Kawasaki H., Suzuki K., Yahara I., Sakai H., and Nishida E. (1991) Xenopus M phase MAP kinase: isolation of its cDNA and activation by MPF. EMBO J. 10, 2661-2668.
7. Greene L. A. and Tischler A. S. (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 73, 2424-2428.
8. Gu W., Schneider J. W., Condorelli G., Kaushal S., Mahdavi V., and Nadal-Ginard B. (1993) Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72, 309-324.
9. Hashimoto Y., Matuoka K., Takenawa T., Muroya K., Hattori S., and Nakamura S. (1994) Different interactions of Grb2/Ash molecule with the NGF and EGF receptors in rat pheochromocytoma PC12 cells. Oncogene 9, 869-875.
10. Hunter T. (1993) Braking the cycle. Cell 75, 839-841.
11. Hunter T. and Pines J. (1994) Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 79, 573-582.
12. Jacks T., Fazeli A., Schmitt E. M., Bronson R. T., Goodell M. A., and Weinberg R. A. (1992) Effects of an Rb mutation in the mouse. Nature 359, 295-300.
13. Kalman D., Whittaker K., Bishop J. M., and O'lague P. H. (1993) Domains of E1A that bind p105Rb, p130, and p300 are required to block nerve growth factor-induced neurite growth in PC12 cells. Mol. Biol. Cell 4, 353-361.
14. Kato J. Y., Matsuoka M., Polyak K., Massague J., and Sherr C. J. (1994) Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kipl) of cyclin-dependent kinase 4 activation. Cell 79, 487-496.
15. Kim S.-J. Wagner S., Liu F., O'Reilly M. A., Robbins P. D., and Green M. R. (1992) Retinoblastoma gene product activates expression of the human TGF-B2 gene through transcription factor ATF-2. Nature 358, 331-334.
16. Kiyokawa H., Richon V. M., Venta-Perez G., Rifkind R. A., and Marks P. A. (1993) Hexamethylenebisacetamide-induced erythroleukemia cell differentiation involves modulation of events required for cell cycle progression through G1. Proc. Natl. Acad. Sci. USA 90, 6746-6750.
17. Kiyokawa H., Richon V. M., Rifkind R. A., and Marks P. A. (1994) Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells. Mol. Cell. Biol. 14, 7195-7203.
18. Koff A., Ohtsuki M., Polyak K., Roberts J. M., and Massague J. (1993) Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta. Science 260, 536-539.
19. Lee E. Y., Chang C. Y., Hu N., Wang Y. C., Lai C. C., Herrup K., Lee W. H., and Bradley A. (1992) Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359, 288-294.
20. Lee E. Y., Hu N., Yuan S. S., Cox L. A., Bradley A., Lee W. H., and Herrup K. (1994) Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev. 8, 2008-2021.
21. Maisel J., Klement V., Lai M. M.-C., Ostertag W., and Deusberg P. (1973) Ribonucleic acid components of murine sarcoma and leukemia viruses. Proc. Natl. Acad. Sci. USA 70, 3536-3540.
22. Marshall C. J. (1991) Tumor suppressor genes. Cell 64, 313-326.
23. Muroya K., Hattori S., and Nakamura S. (1992) Nerve growth factor induces rapid accumulation of the GTP-bound form of p21ras in rat pheochromocytoma PC12 cells. Oncogene 7, 277-281.
24. Noda A., Hing Y., Venable S. F., Pereira-Smith O. M., and Smith J. R. (1994) Cloning of senescent cell-derived inhibitors of DNA synthesis using expression screening. Exp. Cell Res. 211, 90-98.
25. Polyak K., Kato J. Y., Solomon M. J., Sherr C. J., Massague J., Roberts J. M., and Koff A. (1994a) p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8, 9-22.
26. Polyak K., Lee M. H., Erdjument-Bromage H., Koff A., Roberts J. M., Tempst P., and Massague J. (1994b) Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59-66.
27. Qiu M. S. and Green S. H. (1991) NGF and EGF rapidly activate p21ras in PC12 cells by distinct, convergent pathways involving tyrosine phosphorylation. Neuron 7, 937-946.
28. Rudkin B. B., Lazarovici P., Levi B. Z., Abe Y., Fujita K., and Guroff G. (1989) Cell cycle-specific action of nerve growth factor in PC12 cells: differentiation without proliferation. EMBO J. 8, 3319-3325.
29. Satoh T., Nakamura S., and Kaziro Y. (1987) Induction of neurite formation in PC12 cells by microinjection of proto-oncogenic Ha-ras protein preincubated with guanosine-5′-O-(3-thiotriphosphate). Mol. Cell. Biol. 7, 4553-4556.
30. Schneider J. W., Gu W., Zhu L., Mahdavi V., and Nadal-Ginard B. (1994) Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells. Science 264, 1467-1471.
31. Sherr C. J. (1993) Mammalian G1 cyclins. Cell 73, 1059-1065.
32. Singh P., Coe J., and Hong W. (1995) A role for retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor. Nature 374, 562-565.
33. Slingerland J. M., Hengst L., Pan C. H., Alexander D., Stampfer M. R., and Reed S. I. (1994) A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells. Mol. Cell. Biol. 14, 3683-3694.
34. Stein G. H., Beeson M., and Gordon L. (1990) Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts. Science 249, 666-669.
35. Szeberényi J., Cai H., and Cooper G. M. (1990) Effect of a dominant inhibitory Ha-ras mutation on neuronal differentiation of PC12 cells. Mol. Cell. Biol. 10, 5324-5332.
36. Tanaka S., Hattori S., Kurata T., Nagashima K., Fukui Y., Nakamura S., and Matsuda M. (1993) Both the SH2 and SH3 domains of human CRK protein are required for neuronal differentiation of PC12 cells. Mol. Cell. Biol. 13, 4409-4415.
37. Toyoshima H. and Hunter T. (1994) p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78, 67-74.
38. Udvadia A. J., Templeton D. J., and Horowitz J. M. (1995) Functional interactions between the retinoblastoma (Rb) protein and Sp-family members: superactivation by Rb requires amino acids necessary for growth suppression. Proc. Natl. Acad. Sci. USA 92, 3953-3957.
39. Weinberg R. A. (1995) The retinoblastoma protein and cell cycle control. Cell 81, 323-330.
40. Welch P. J. and Wang J. Y. (1993) A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 75, 779-790.
41. Welch P. J. and Wang J. Y. (1995) Disruption of retinoblastoma protein function by coexpression of its C pocket fragment. Genes Dev. 9, 31-46.
42. Xiong Y., Hannon G. J., Zhang H., Casso D., Kobayashi R., and Beach D. (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-704.
43. Yan G. and Ziff E. B. (1995) NGF regulates the PC12 cell cycle machinery through specific inhibition of the cdk kinases and induction of cyclin D1. J. Neurosci. 15, 6200-6212.